Study to Evaluate the Efficacy of GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine in Adults

Clinical trial NCT01755598 · COMPLETED

Trial details

NCT number: NCT01755598
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Tuberculosis Tuberculosis Vaccines

Start date: 2014-08-19
Primary completion: 2018-11-16
Enrollment: 3575

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.